Literature DB >> 8323075

Prognostic differences of adenocarcinoma arising from the cardia and the upper third of the stomach.

Y Nakane1, S Okamura, T Boku, T Okusa, K Tanaka, K Hioki.   

Abstract

Of 1,012 patients who underwent gastrectomy for carcinoma of the stomach from 1980 to 1990, 33 with adenocarcinoma arising from the gastroesophageal junction (group C) and 55 with adenocarcinoma of the upper third of the stomach (group U) were compared with regard to their clinicopathologic features. Twenty-five patients (76%) in group C and 49 patients (89%) in group U underwent curative resection. The 5-year survival rates following curative resection were 32 and 70 per cent, respectively (P < 0.001). The poor prognosis of group C was ascribed to a greater propensity for esophageal invasion and nodal involvement, as well as to more advanced disease at diagnosis. The rich lymphatic drainage around the cardia may account for the wide spread of such tumors. Most patients presented with an advanced disease, so earlier detection of carcinoma of the cardia is mandatory to improve the results of surgery. At operation, it is important to dissect all the involved lymph nodes from the mediastinum to the abdominal paraaortic nodes and to ensure a tumor-free esophageal margin.

Entities:  

Mesh:

Year:  1993        PMID: 8323075

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  5 in total

1.  Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia.

Authors:  Yung-Chang Lien; Chih-Cheng Hsieh; Yu-Chung Wu; Han-Shui Hsu; Wen-Hu Hsu; Liang-Shun Wang; Min-Hsiung Huang; Biing-Shiun Huang
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

2.  Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction.

Authors:  Norihiro Yuasa; Hideo Miyake; Tatsuharu Yamada; Tomoki Ebata; Yuji Nimura; Tatsuo Hattori
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

3.  Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis.

Authors:  Aiqin Sun; Guanzhen Yu; Xiaoyan Dou; Xiaowei Yan; Wannian Yang; Qiong Lin
Journal:  Mol Cancer       Date:  2014-11-14       Impact factor: 27.401

4.  CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma.

Authors:  Jing Wei; Guanzhen Yu; Genbao Shao; Aiqin Sun; Miao Chen; Wannian Yang; Qiong Lin
Journal:  Oncotarget       Date:  2016-05-24

5.  The Hippo signaling effector WWTR1 is a metastatic biomarker of gastric cardia adenocarcinoma.

Authors:  Jing Wei; Lincui Wang; Jun Zhu; Aiqin Sun; Guanzhen Yu; Miao Chen; Pan Huang; Hanqing Liu; Genbao Shao; Wannian Yang; Qiong Lin
Journal:  Cancer Cell Int       Date:  2019-03-29       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.